Airway Lipoxin A(4) Generation and Lipoxin A(4) Receptor Expression Are Decreased in Severe Asthma

Rationale: Airway inflammation is common in severe asthma despite antiinflammatory therapy with corticosteroids. Lipoxin A(4) (LXA(4)) is an arachidonic acid–derived mediator that serves as an agonist for resolution of inflammation. Objectives: Airway levels of LXA(4), as well as the expression of l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Planagumà, Anna, Kazani, Shamsah, Marigowda, Gautham, Haworth, Oliver, Mariani, Thomas J., Israel, Elliot, Bleecker, Eugene R., Curran-Everett, Douglas, Erzurum, Serpil C., Calhoun, William J., Castro, Mario, Chung, Kian Fan, Gaston, Benjamin, Jarjour, Nizar N., Busse, William W., Wenzel, Sally E., Levy, Bruce D.
Formato: Artigo
Idioma:Inglês
Publicado em: American Thoracic Society 2008
Assuntos:
A. Asthma and Allergy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2542432/
https://ncbi.nlm.nih.gov/pubmed/18583575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.200801-061OC
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados